Antiarrhythmic effect due to prolongation of the cardiac action potential and inhibition of norepinephrine reuptake by sympthetic nerves

Bretylium infusions are used to treat ventricular fibrillation in emergent circumstances with the aim of control and prevention of recurrence. No longer a first-line agent.